Market Overview

UPDATE: Stifel Nicolaus Downgrades Comerica to Sell on Premium Valuation, Low ROA

Share:
Related CMA
Benzinga's M&A Chatter for Tuesday April 26, 2016
CLSA's Mike Mayo Talks Comerica's Annual Meeting: Management Is 'Finally Listening'
Medtronic names new finance chief (Seeking Alpha)

Stifel Nicolaus downgraded Comerica (NYSE: CMA) from Hold to Sell.

Stifel Nicolaus commented, "The shares are trading at a 25% premium to the rest of our large cap bank coverage universe despite having one of the lowest projected ROAs. With approximately 72% of the company's earning assets tied to the short-end of the yield curve (not the long end), we believe the market is way ahead of itself in assuming just how much the company benefits from the recent rise in long-term interest rates."

Comerica closed at $35.77 on Friday.

Latest Ratings for CMA

DateFirmActionFromTo
Apr 2016Bank of AmericaUpgradesUnderperformNeutral
Apr 2016JP MorganMaintainsNeutral
Apr 2016BarclaysMaintainsUnderweight

View More Analyst Ratings for CMA
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CMA)

View Comments and Join the Discussion!